125 related articles for article (PubMed ID: 12825200)
1. Contribution of the rev gene to the immunogenicity of DNA vaccines targeting the envelope glycoprotein of HIV.
Jounai N; Okuda K; Kojima Y; Toda Y; Hamajima K; Ohba K; Klinman D; Xin KQ
J Gene Med; 2003 Jul; 5(7):609-17. PubMed ID: 12825200
[TBL] [Abstract][Full Text] [Related]
2. Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost.
Shinoda K; Xin KQ; Kojima Y; Saha S; Okuda K; Okuda K
Clin Immunol; 2006 Apr; 119(1):32-7. PubMed ID: 16458074
[TBL] [Abstract][Full Text] [Related]
3. A DNA vaccine containing inverted terminal repeats from adeno-associated virus increases immunity to HIV.
Xin KQ; Ooki T; Jounai N; Mizukami H; Hamajima K; Kojima Y; Ohba K; Toda Y; Hirai S; Klinman DM; Ozawa K; Okuda K
J Gene Med; 2003 May; 5(5):438-45. PubMed ID: 12731092
[TBL] [Abstract][Full Text] [Related]
4. Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein.
Kaneko H; Bednarek I; Wierzbicki A; Kiszka I; Dmochowski M; Wasik TJ; Kaneko Y; Kozbor D
Virology; 2000 Feb; 267(1):8-16. PubMed ID: 10648178
[TBL] [Abstract][Full Text] [Related]
5. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
6. Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.
Shinoda K; Xin KQ; Jounai N; Kojima Y; Tamura Y; Okada E; Kawamoto S; Okuda K; Klinman D; Okuda K
Vaccine; 2004 Sep; 22(27-28):3676-90. PubMed ID: 15315847
[TBL] [Abstract][Full Text] [Related]
7. Effect of partial and complete variable loop deletions of the human immunodeficiency virus type 1 envelope glycoprotein on the breadth of gp160-specific immune responses.
Gzyl J; Bolesta E; Wierzbicki A; Kmieciak D; Naito T; Honda M; Komuro K; Kaneko Y; Kozbor D
Virology; 2004 Jan; 318(2):493-506. PubMed ID: 14972518
[TBL] [Abstract][Full Text] [Related]
8. DNA prime/protein boost immunization against HIV clade C: safety and immunogenicity in mice.
Rasmussen RA; Ong H; Kittel C; Ruprecht CR; Ferrantelli F; Hu SL; Polacino P; McKenna J; Moon J; Travis B; Ruprecht RM
Vaccine; 2006 Mar; 24(13):2324-32. PubMed ID: 16406147
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
Jiang W; Ren L; Jin N
J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
[TBL] [Abstract][Full Text] [Related]
10. 8 Br-cAMP enhances both humoral and cell-mediated immune responses induced by an HIV-1 DNA vaccine.
Arai H; Xin KQ; Hamajima K; Lu Y; Watabe S; Takahashi T; Toda S; Okuda K; Kudoh I; Suzuki M; Okuda K
Gene Ther; 2000 Apr; 7(8):694-702. PubMed ID: 10800093
[TBL] [Abstract][Full Text] [Related]
11. Immunization of RANTES expression plasmid with a DNA vaccine enhances HIV-1-specific immunity.
Xin KQ; Lu Y; Hamajima K; Fukushima J; Yang J; Inamura K; Okuda K
Clin Immunol; 1999 Jul; 92(1):90-6. PubMed ID: 10413656
[TBL] [Abstract][Full Text] [Related]
12. Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine.
Wang S; Farfan-Arribas DJ; Shen S; Chou TH; Hirsch A; He F; Lu S
Vaccine; 2006 May; 24(21):4531-40. PubMed ID: 16140431
[TBL] [Abstract][Full Text] [Related]
13. [Immunogenicity of plasmid DNA and adenoviral vectors encoding HIV-1 subtype B env gene].
Yang HR; Zhang LF; Feng X; Yu SQ; Zhuang ZL; Li HX; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):415-7. PubMed ID: 21604562
[TBL] [Abstract][Full Text] [Related]
14. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
Gómez CE; Abaitua F; Rodríguez D; Esteban M
Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
[TBL] [Abstract][Full Text] [Related]
15. Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV.
Xin KQ; Jounai N; Someya K; Honma K; Mizuguchi H; Naganawa S; Kitamura K; Hayakawa T; Saha S; Takeshita F; Okuda K; Honda M; Klinman DM; Okuda K
Gene Ther; 2005 Dec; 12(24):1769-77. PubMed ID: 16079886
[TBL] [Abstract][Full Text] [Related]
16. Immunization with HIV-1 subtype B gp160-DNA induces specific as well as cross reactive immune responses in mice.
Arora A; Seth P
Indian J Med Res; 2001 Jul; 114():1-9. PubMed ID: 11762199
[TBL] [Abstract][Full Text] [Related]
17. [Combination immunization with EIAV Env protein expressed by recombinant baculovirus and recombinant vaccinia virus containing env gene].
Dai CM; Zhang XY; Zhang RR; Shao YM; Shen RX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jul; 20(4):410-4. PubMed ID: 15207082
[TBL] [Abstract][Full Text] [Related]
18. Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccine.
Akahata W; Yang ZY; Nabel GJ
J Virol; 2005 Jan; 79(1):626-31. PubMed ID: 15596858
[TBL] [Abstract][Full Text] [Related]
19. The simian immunodeficiency virus (SIV) rev gene regulates env expression.
Cheng SM; Blume M; Lee SG; Hung PP; Hirsch VM; Johnson PR
J Med Primatol; 1990; 19(3-4):167-76. PubMed ID: 2231681
[TBL] [Abstract][Full Text] [Related]
20. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.
McBurney SP; Young KR; Ross TM
Virology; 2007 Feb; 358(2):334-46. PubMed ID: 17011011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]